Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy
Clinical trial NCT01594177 · COMPLETED
Trial details
- NCT number
- NCT01594177
- Sponsor
- GBG Forschungs GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2014-03-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.